<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ABBV
AbbVie
$
()


  • What You Missed On Wall Street On Friday

    5/17/2024 - 16:10pm
  • What You Missed On Wall Street This Morning

    5/17/2024 - 11:50am
  • Robinhood upgraded, Baidu downgraded: Wall Street's top analyst calls

    5/17/2024 - 09:38am
  • AbbVie initiated with bullish view at Cantor Fitzgerald, here's why

    5/17/2024 - 07:05am
  • AbbVie initiated with bullish view at Cantor Fitzgerald

    5/17/2024 - 06:09am
  • AbbVie, Gilgamesh Pharmaceuticals to co-develop psychiatric disorder therapies

    5/13/2024 - 08:41am
  • Genmab reports Q1 revenue increased 46% vs. last year

    5/2/2024 - 11:06am
  • AbbVie price target lowered by $15 at BMO Capital, here's why

    4/29/2024 - 09:49am
  • AbbVie price target lowered by $5 at Morgan Stanley, here's why

    4/29/2024 - 08:56am
  • AbbVie price target lowered by $8 at Barclays, here's why

    4/29/2024 - 05:47am
  • What You Missed On Wall Street On Friday

    4/26/2024 - 16:08pm
  • What You Missed On Wall Street This Morning

    4/26/2024 - 12:03pm
  • AbbVie says Humira downdraft 'within what was assumed'

    4/26/2024 - 10:00am
  • AbbVie sees FY24 revenue approximately $55B, consensus $54.6B

    4/26/2024 - 09:39am
  • AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $2.81

    4/26/2024 - 09:36am
dynamic_feed Breaking News